{"id":37177,"date":"2025-10-27T09:16:31","date_gmt":"2025-10-27T08:16:31","guid":{"rendered":"https:\/\/semaxpolska.com\/?p=37177"},"modified":"2026-04-01T03:57:29","modified_gmt":"2026-04-01T01:57:29","slug":"ivermektin-na-demodex-roztoce","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/sk\/iwermektyna-na-demodex-nuzeniec\/","title":{"rendered":"Ivermekt\u00edn na Demodex (\u010dervoto\u010d) - \u00fa\u010dinn\u00e1 met\u00f3da boja proti ko\u017en\u00fdm probl\u00e9mom"},"content":{"rendered":"<h2>Opis mo\u017en\u00fdch \u00fa\u010dinkov l\u00e1tky Ivermekt\u00edn na z\u00e1klade literat\u00fary. (Toto nie je opis v\u00fdrobku, vyhl\u00e1senie o vyl\u00fa\u010den\u00ed zodpovednosti sa nach\u00e1dza na konci str\u00e1nky)<\/h2>\n<p>Ivermekt\u00edn na Demodex (nu\u017eenca) sa \u010doraz \u010dastej\u0161ie diskutuje ako jedna z met\u00f3d podporuj\u00facich boj s ko\u017en\u00fdmi probl\u00e9mami spojen\u00fdmi s pr\u00edtomnos\u0165ou rozto\u010dov Demodex. V posledn\u00fdch rokoch z\u00e1ujem o t\u00fato zl\u00fa\u010deninu v\u00fdrazne vzr\u00e1stol, najm\u00e4 v kontexte v\u00fdskumu jej mechanizmu \u00fa\u010dinku a pozorovan\u00ed pou\u017e\u00edvate\u013eov.<\/p>\n<p>V ko\u017ei sa nach\u00e1dza mno\u017estvo mikroorganizmov, ktor\u00e9 zvy\u010dajne \u017eij\u00fa v harm\u00f3nii s organizmom. Medzi ne patria rozto\u010de <i>Demodex v Po\u013esku zn\u00e1my ako <strong>cysticerk\u00f3za<\/strong><\/i>, mikroskopick\u00e9 organizmy ob\u00fdvaj\u00face vlasov\u00e9 folikuly a mazov\u00e9 \u017e\u013eazy. U \u013eud\u00ed sa vyskytuj\u00fa dva hlavn\u00e9 druhy: <i>Demodex folliculorum <\/i>i <i>Demodex brevis<\/i>. Hoci s\u00fa vo v\u0161eobecnosti ne\u0161kodn\u00e9, ich nekontrolovan\u00e9 premno\u017eenie m\u00f4\u017ee vies\u0165 k probl\u00e9mom s poko\u017ekou a o\u010dami. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1367048419300530\" target=\"_blank\" rel=\"noopener\"><sup>(1)<\/sup><\/a><\/p>\n<p>Pre\u013eudnenie <i>Demodex <\/i>sa sp\u00e1ja so stavmi, ako s\u00fa rosacea, demodekt\u00f3za, z\u00e1pal o\u010dn\u00fdch vie\u010dok a keratit\u00edda. Pr\u00edznaky m\u00f4\u017eu zah\u0155\u0148a\u0165 svrbenie, za\u010dervenanie, papuly, pustuly alebo \u0161upinat\u00e9 vie\u010dka, \u010dasto pripom\u00ednaj\u00face akn\u00e9 alebo dermatit\u00eddu. Kv\u00f4li t\u00fdmto podobnostiam sa diagn\u00f3za \u010dasto odklad\u00e1, \u010do predl\u017euje \u0165a\u017ekosti a komplikuje lie\u010dbu. Star\u0161\u00ed \u013eudia, pacienti s oslaben\u00fdm imunitn\u00fdm syst\u00e9mom alebo pacienti s mastnou poko\u017ekou maj\u00fa tendenciu k vy\u0161\u0161ej miere infekcie, \u010do poukazuje na \u00falohu faktorov s\u00favisiacich s hostite\u013eom pri vzniku ochorenia. Tradi\u010dn\u00e9 sp\u00f4soby lie\u010dby - ako s\u00fa permetr\u00edn, metronidazol a s\u00edrne pr\u00edpravky - m\u00f4\u017eu zn\u00ed\u017ei\u0165 popul\u00e1ciu rozto\u010dov, ale \u010dasto s\u00fa obmedzen\u00e9 ne\u00fapln\u00fdm odstr\u00e1nen\u00edm, recid\u00edvou a podr\u00e1\u017eden\u00edm. Tieto nedostatky viedli k zv\u00fd\u0161en\u00e9mu z\u00e1ujmu o nov\u0161ie terapie, ktor\u00e9 s\u00fa \u00fa\u010dinn\u00e9 a lep\u0161ie tolerovan\u00e9. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1367048419300530\" target=\"_blank\" rel=\"noopener\"><sup>1)<\/sup><\/a>\u00a0 (<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10792-016-0249-9\" target=\"_blank\" rel=\"noopener\"><sup>2)<\/sup><\/a><\/p>\n<p>Ivermekt\u00edn, liek prv\u00fdkr\u00e1t zaveden\u00fd na lie\u010dbu parazit\u00e1rnych infekci\u00ed, sa v tejto oblasti uk\u00e1zal ako mimoriadne s\u013eubn\u00fd. P\u00f4sob\u00ed nielen priamo na rozto\u010de <i>Demodex<\/i>ale tie\u017e zni\u017euje z\u00e1pal, \u010d\u00edm odstra\u0148uje jeho pr\u00ed\u010dinu a n\u00e1sledn\u00e9 podr\u00e1\u017edenie poko\u017eky. Topick\u00fd ivermekt\u00edn 1% je u\u017e schv\u00e1len\u00fd na lie\u010dbu rosacey, zatia\u013e \u010do peror\u00e1lne formy sa sk\u00famaj\u00fa na \u0161ir\u0161ie pou\u017eitie pri ochoreniach s\u00favisiacich s rozto\u010dmi. Tento \u010dl\u00e1nok sa zaober\u00e1 \u00falohou ivermekt\u00ednu pri kontrole <i>Demodex, <\/i>jej v\u00fdhody oproti konven\u010dn\u00fdm lie\u010debn\u00fdm postupom a jej potenci\u00e1l ako prim\u00e1rnej terapie na zlep\u0161enie zdravia poko\u017eky a kvality \u017eivota. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1367048419300530\" target=\"_blank\" rel=\"noopener\"><sup>1)<\/sup><\/a>\u00a0 (<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10792-016-0249-9\" target=\"_blank\" rel=\"noopener\"><sup>2)<\/sup><\/a><\/p>\n<h2>Demodex pri ko\u017en\u00fdch a o\u010dn\u00fdch ochoreniach<\/h2>\n<h3>Ochorenia ko\u017ee s\u00favisiace s demodexom<\/h3>\n<p>Hoci rozto\u010de <i>Demodex <\/i>s\u00fa be\u017en\u00fdmi komenz\u00e1lmi a ich premno\u017eenie m\u00e1 siln\u00fd vplyv na viacer\u00e9 dermatologick\u00e9 ochorenia. Najzn\u00e1mej\u0161\u00edm z nich je rosacea, pri ktorej pacienti neust\u00e1le vykazuj\u00fa vy\u0161\u0161iu hustotu rozto\u010dov v porovnan\u00ed so zdrav\u00fdmi jedincami. Metaanal\u00fdza uverejnen\u00e1 v \u010dasopise <i>Journal of the American Academy of Dermatology (2012) <\/i>uk\u00e1zali, \u017ee u \u013eud\u00ed s rosaceou je takmer osemkr\u00e1t vy\u0161\u0161ia pravdepodobnos\u0165, \u017ee bud\u00fa infikovan\u00ed<i> Demodex<\/i>, najm\u00e4 pri papulopustul\u00e1rnych podtypoch. Predpoklad\u00e1 sa, \u017ee tieto rozto\u010de blokuj\u00fa vlasov\u00e9 folikuly a stimuluj\u00fa z\u00e1palov\u00e9 kask\u00e1dy, \u010do vedie k za\u010dervenaniu, pustul\u00e1m a papul\u00e1m. (<a href=\"http:\/\/www.geriatri.dergisi.org\/uploads\/pdf\/pdf_TJG_982.pdf\" target=\"_blank\" rel=\"noopener\"><sup>3)<\/sup><\/a><\/p>\n<p>\u010eal\u0161ia porucha, prim\u00e1rna demodekoza, sa vyskytuje vtedy, ke\u010f rozto\u010de samy sp\u00f4sobuj\u00fa patol\u00f3giu bez in\u00fdch z\u00e1kladn\u00fdch ochoren\u00ed. Klinick\u00e9 \u0161t\u00fadie uk\u00e1zali, \u017ee zn\u00ed\u017eenie popul\u00e1cie rozto\u010dov pomocou repelentov vedie k v\u00fdrazn\u00e9mu zlep\u0161eniu eryt\u00e9mu, \u0161upinatej ko\u017ee a pruritu, \u010do potvrdzuje priamu \u00falohu <i>Demodex<\/i> v patogen\u00e9ze<i>. <\/i>Okrem rosacey sa nadmern\u00e9 zamorenie rozto\u010dmi sp\u00e1ja aj s perior\u00e1lnou dermatit\u00eddou a l\u00e9ziami podobn\u00fdmi akn\u00e9 a pr\u00edpadov\u00e9 spr\u00e1vy nazna\u010duj\u00fa, \u017ee nespr\u00e1vna diagn\u00f3za bakteri\u00e1lneho akn\u00e9 \u010dasto od\u010fa\u013euje \u00fa\u010dinn\u00fa lie\u010dbu. (<a href=\"http:\/\/www.geriatri.dergisi.org\/uploads\/pdf\/pdf_TJG_982.pdf\" target=\"_blank\" rel=\"noopener\"><sup>3)<\/sup><\/a><\/p>\n<h3>O\u010dn\u00e9 prejavy<\/h3>\n<p>Rovnako n\u00e1chyln\u00fd je aj povrch oka. V oftalmologick\u00fdch \u0161t\u00fadi\u00e1ch bola dobre zdokumentovan\u00e1 demodexov\u00e1 eyelidit\u00edda, chronick\u00fd z\u00e1pal o\u010dn\u00fdch vie\u010dok. V jednej \u0161t\u00fadii sa u takmer 841 pacientov s chronick\u00fdm z\u00e1palom o\u010dn\u00fdch vie\u010dokTP21T zistili rozto\u010de <i>Demodex<\/i>. Medzi klinick\u00e9 pr\u00edznaky patria valcovit\u00e9 lupiny na b\u00e1ze mihaln\u00edc, ktor\u00e9 s\u00fa spo\u013eahliv\u00fdm indik\u00e1torom napadnutia.<\/p>\n<p>Nelie\u010den\u00e1 infekcia m\u00f4\u017ee vies\u0165 k dysfunkcii Meibomovej \u017e\u013eazy a prispie\u0165 k rozvoju syndr\u00f3mu such\u00e9ho oka. V\u00fdskum uverejnen\u00fd v \u010dasopise <i>Investigative Ophthalmology &amp; Visual Science (2011) <\/i>potvrdili, \u017ee hustota rozto\u010dov koreluje s blok\u00e1dou Meibomovej \u017e\u013eazy a z\u00e1va\u017enos\u0165ou pr\u00edznakov syndr\u00f3mu such\u00e9ho oka. V zriedkav\u00fdch, ale z\u00e1va\u017en\u00fdch pr\u00edpadoch m\u00f4\u017ee napadnutie sp\u00f4sobi\u0165 keratit\u00eddu, ktor\u00e1 hroz\u00ed stratou zraku. Ke\u010f\u017ee pr\u00edznaky - p\u00e1lenie, svrbenie a pocit cudzieho telesa - sa prekr\u00fdvaj\u00fa s pr\u00edznakmi alergickej konjunktivit\u00eddy a syndr\u00f3mu such\u00e9ho oka, diagn\u00f3za sa \u010dasto odklad\u00e1. (<a href=\"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2126338\" target=\"_blank\" rel=\"noopener\"><sup>4)<\/sup><\/a><\/p>\n<h2>Rizikov\u00e9 faktory a zranite\u013en\u00e9 skupiny<\/h2>\n<p>Niektor\u00e9 skupiny obyvate\u013estva s\u00fa vystaven\u00e9 vy\u0161\u0161iemu riziku symptomatick\u00e9ho napadnutia. U star\u0161\u00edch \u013eud\u00ed je v\u00fdskyt rozto\u010dov vy\u0161\u0161\u00ed; v jednej \u010d\u00ednskej kohortovej \u0161t\u00fadii sa uv\u00e1dza v\u00fdskyt presahuj\u00faci 80% u \u013eud\u00ed star\u0161\u00edch ako 60 rokov v porovnan\u00ed s menej ako 30% u \u013eud\u00ed mlad\u0161\u00edch ako 20 rokov. Pripisuje sa to oslabeniu imunity s\u00favisiacemu s vekom a zmen\u00e1m v produkcii ko\u017en\u00e9ho mazu. <a href=\"https:\/\/link.springer.com\/article\/10.1631\/jzus.B1100079\" target=\"_blank\" rel=\"noopener\"><sup>(5)<\/sup><\/a><\/p>\n<p>U pacientov s oslabenou imunitou, ako s\u00fa pr\u00edjemcovia transplant\u00e1tov alebo dlhodob\u00ed u\u017e\u00edvatelia kortikosteroidov, sa \u010dasto vyskytuj\u00fa z\u00e1va\u017enej\u0161ie a \u0165a\u017e\u0161ie pr\u00edpady nevo\u013enosti. V s\u00e9rii pr\u00edpadov sa opisuje fulminantn\u00e1 demodekt\u00f3za tv\u00e1re u imunokompromitovan\u00fdch pacientov, ktor\u00e1 ust\u00fapila a\u017e po cielenej akaric\u00eddnej lie\u010dbe. Medzi \u010fal\u0161ie rizikov\u00e9 faktory patr\u00ed mastn\u00e1 ple\u0165, chronick\u00e9 u\u017e\u00edvanie steroidov a s\u00fa\u010dasn\u00fd v\u00fdskyt seboroickej alebo atopickej dermatit\u00eddy, ktor\u00e9 vytv\u00e1raj\u00fa priazniv\u00e9 podmienky na rozmno\u017eovanie rozto\u010dov. (<a href=\"https:\/\/link.springer.com\/article\/10.1631\/jzus.B1100079\" target=\"_blank\" rel=\"noopener\"><sup>()\u00a0 (6)\u00a0 ())<\/sup><\/a><\/p>\n<h2>Diagnostick\u00e9 v\u00fdzvy<\/h2>\n<p>Pretrv\u00e1vaj\u00facim probl\u00e9mom pri lie\u010dbe ochoren\u00ed s\u00favisiacich s Demodexom je ich ne\u0161pecifick\u00fd klinick\u00fd obraz. Pr\u00edznaky ako za\u010dervenanie, svrbenie alebo pupienky s\u00fa spolo\u010dn\u00e9 pre acne vulgaris, seboroick\u00fa dermatit\u00eddu a rosaceu. Pri o\u010dn\u00fdch ochoreniach je diagnostika komplikovan\u00e1 prekr\u00fdvan\u00edm pr\u00edznakov alergickej konjunktivit\u00eddy a syndr\u00f3mu such\u00e9ho oka. Zlat\u00fdm \u0161tandardom pre diagnostiku zost\u00e1va priame pozorovanie pod sveteln\u00fdm mikroskopom. Zvy\u010dajne sa pri h\u013eadan\u00ed rozto\u010dov vy\u0161etruj\u00fa ko\u017en\u00e9 zo\u0161krabky alebo vytrhnut\u00e9 mihalnice. Nov\u0161ie met\u00f3dy, ako napr\u00edklad konfok\u00e1lna mikroskopia, v\u0161ak umo\u017e\u0148uj\u00fa zobrazenie rozto\u010dov vo vlasov\u00fdch folikuloch in vivo, \u010do zvy\u0161uje presnos\u0165 diagnostiky. Napriek t\u00fdmto pokrokom nie s\u00fa tieto n\u00e1stroje v klinickej praxi be\u017ene dostupn\u00e9, \u010do znamen\u00e1, \u017ee <i>Demodex <\/i>je st\u00e1le nedostato\u010dne diagnostikovan\u00fdm p\u00f4vodcom chronick\u00fdch ko\u017en\u00fdch a o\u010dn\u00fdch ochoren\u00ed. (<a href=\"https:\/\/journals.lww.com\/ijd\/fulltext\/2012\/57010\/facial_demodicidosis__a_diagnostic_challenge.22.aspx\" target=\"_blank\" rel=\"noopener\"><sup>7)<\/sup><\/a><\/p>\n<h2>Tradi\u010dn\u00e9 pr\u00edstupy a ich obmedzenia<\/h2>\n<h3>Lok\u00e1lna lie\u010dba: metronidazol a permetr\u00edn<\/h3>\n<p>Dlh\u00e9 roky boli najbe\u017enej\u0161ou lie\u010dbou ko\u017en\u00fdch ochoren\u00ed s\u00favisiacich s Demodexom lok\u00e1lne pr\u00edpravky ako metronidazol a permetr\u00edn. Metronidazol sa \u0161iroko pou\u017e\u00edva pri lie\u010dbe rosacey kv\u00f4li jeho protiz\u00e1palov\u00e9mu \u00fa\u010dinku, ale jeho schopnos\u0165 zn\u00ed\u017ei\u0165 po\u010det rozto\u010dov je obmedzen\u00e1. To znamen\u00e1, \u017ee u pacientov m\u00f4\u017ee d\u00f4js\u0165 k zlep\u0161eniu za\u010dervenania a podr\u00e1\u017edenia, zatia\u013e \u010do popul\u00e1cia rozto\u010dov zost\u00e1va nezmenen\u00e1, \u010do \u010dasto vedie k recid\u00edve po lie\u010dbe. Na druhej strane permetr\u00edn m\u00e1 silnej\u0161\u00ed \u00fa\u010dinok na ni\u010denie rozto\u010dov a \u010dasto sa predpisuje ako kr\u00e9m. Hoci dok\u00e1\u017ee zn\u00ed\u017ei\u0165 hustotu popul\u00e1cie rozto\u010dov, zriedka vedie k \u00faplnej eradik\u00e1cii a v niektor\u00fdch pr\u00edpadoch sa pozoruje len \u010diasto\u010dn\u00e9 zlep\u0161enie. Pri opakovanom pou\u017e\u00edvan\u00ed m\u00f4\u017ee tie\u017e existova\u0165 riziko zn\u00ed\u017eenej citlivosti alebo rezistencie na liek. Pacienti \u010dasto uv\u00e1dzaj\u00fa pretrv\u00e1vaj\u00face svrbenie a z\u00e1pal aj po nieko\u013ek\u00fdch cykloch lie\u010dby. (<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/dth.13103\" target=\"_blank\" rel=\"noopener\"><sup>8)<\/sup><\/a><\/p>\n<h3>Bylinn\u00e9 a pr\u00edrodn\u00e9 prostriedky<\/h3>\n<p>Sk\u00famala sa aj schopnos\u0165 pr\u00edrodn\u00fdch prostriedkov, ako je \u010dajovn\u00edkov\u00fd olej, ni\u010di\u0165 rozto\u010de. Vo vy\u0161\u0161\u00edch koncentr\u00e1ci\u00e1ch m\u00f4\u017ee \u010dajovn\u00edkov\u00fd olej znehybni\u0165 a zlikvidova\u0165 <i>Demodex<\/i>, preto sa zrieden\u00e9 pr\u00edpravky niekedy pou\u017e\u00edvaj\u00fa na hygienu o\u010dn\u00fdch vie\u010dok v pr\u00edpade demodekozy o\u010d\u00ed.<\/p>\n<p>Ved\u013eaj\u0161ie \u00fa\u010dinky v\u0161ak obmedzuj\u00fa jeho \u0161irok\u00e9 pou\u017eitie. Koncentrovan\u00fd \u010dajovn\u00edkov\u00fd olej m\u00f4\u017ee sp\u00f4sobi\u0165 p\u00e1lenie, podr\u00e1\u017edenie a dokonca aj alergick\u00e9 reakcie, preto nie je vhodn\u00fd na dlhodob\u00e9 pou\u017e\u00edvanie na citliv\u00fdch miestach, ako s\u00fa napr\u00edklad o\u010dn\u00e9 vie\u010dka. Okrem toho sa v\u00fdrobky dostupn\u00e9 na trhu l\u00ed\u0161ia silou a zlo\u017een\u00edm, \u010do zni\u017euje konzistentnos\u0165 v\u00fdsledkov. Po ukon\u010den\u00ed lie\u010dby sa tie\u017e \u010dasto vyskytuje recid\u00edva. <a href=\"https:\/\/meridian.allenpress.com\/journal-of-parasitology\/article-abstract\/104\/5\/473\/7541\" target=\"_blank\" rel=\"noopener\"><sup>(9)<\/sup><\/a><\/p>\n<h3>Syst\u00e9mov\u00e9 antibiotik\u00e1 a retinoidy<\/h3>\n<p>Peror\u00e1lne lieky, ako s\u00fa antibiotik\u00e1 alebo retinoidy, sa pou\u017e\u00edvaj\u00fa na lie\u010dbu pacientov s refrakt\u00e9rnej\u0161\u00edmi formami rosacey alebo nuscin. Tieto lieky \u00fa\u010dinkuj\u00fa sk\u00f4r tak, \u017ee zni\u017euj\u00fa z\u00e1pal alebo upravuj\u00fa produkciu ko\u017en\u00e9ho mazu, ne\u017e aby priamo odstra\u0148ovali rozto\u010de. V d\u00f4sledku toho mnoh\u00ed pacienti hl\u00e1sia \u010diasto\u010dn\u00fa \u00fa\u013eavu, ale na\u010falej s\u00fa nosite\u013emi zna\u010dn\u00e9ho po\u010dtu rozto\u010dov, \u010do nesk\u00f4r vedie k recid\u00edvam. Dlhodobo pou\u017e\u00edvan\u00e9 antibiotik\u00e1 prin\u00e1\u0161aj\u00fa \u010fal\u0161ie obavy z rezistencie, zatia\u013e \u010do retinoidy m\u00f4\u017eu sp\u00f4sobova\u0165 ved\u013eaj\u0161ie \u00fa\u010dinky, ako je suchos\u0165, podr\u00e1\u017edenie a potreba osobitn\u00fdch opatren\u00ed u \u017eien v plodnom veku. Tieto nev\u00fdhody obmedzuj\u00fa ich u\u017eito\u010dnos\u0165 ako dlhodobej alebo prvej vo\u013eby lie\u010dby ochoren\u00ed s\u00favisiacich s rozto\u010dmi. (<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/dth.13103\" target=\"_blank\" rel=\"noopener\"><sup>10)<\/sup><\/a><\/p>\n<h3>Obmedzenia pri lie\u010dbe o\u010dn\u00fdch ochoren\u00ed<\/h3>\n<p>E\u0161te v\u00e4\u010d\u0161iu v\u00fdzvu predstavuje postihnutie o\u010d\u00ed. \u0160tandardn\u00e9 met\u00f3dy, ako je hygiena o\u010dn\u00fdch vie\u010dok, tepl\u00e9 obklady a umel\u00e9 slzy, m\u00f4\u017eu zmierni\u0165 podr\u00e1\u017edenie, ale nezabr\u00e1nia samotn\u00fdm rozto\u010dom. Niekedy sa pou\u017e\u00edvaj\u00fa antibiotick\u00e9 alebo steroidn\u00e9 kvapky, ale aj tie bojuj\u00fa sk\u00f4r proti z\u00e1palu ako proti jeho pr\u00ed\u010dine. Z tohto d\u00f4vodu mnoh\u00ed pacienti s o\u010dnou demodek\u00f3zou trpia chronick\u00fdmi, opakuj\u00facimi sa pr\u00edznakmi, ktor\u00e9 im s\u0165a\u017euj\u00fa ka\u017edodenn\u00fd \u017eivot. Lie\u010dba, ktor\u00e1 priamo nezlikviduje rozto\u010de, \u010dasto neprin\u00e1\u0161a trval\u00fa \u00fa\u013eavu, \u010do frustruje pacientov aj lek\u00e1rov. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1542012419300655\" target=\"_blank\" rel=\"noopener\"><sup>11)<\/sup><\/a><\/p>\n<h3>Potreba \u00fa\u010dinnej\u0161\u00edch rie\u0161en\u00ed<\/h3>\n<p>Nev\u00fdhody tradi\u010dn\u00fdch terapi\u00ed - \u010di u\u017e z d\u00f4vodu ne\u00faplnej kontroly rozto\u010dov, obmedzenej \u00fa\u010dinnosti, nezn\u00e1\u0161anlivosti zo strany pacientov alebo \u010dast\u00fdch recid\u00edv - zd\u00f4raz\u0148uj\u00fa potrebu n\u00e1js\u0165 lep\u0161ie alternat\u00edvy. Mnoh\u00ed \u013eudia podstupuj\u00fa viacero lok\u00e1lnych alebo peror\u00e1lnych terapi\u00ed bez toho, aby zaznamenali dlhodob\u00e9 zlep\u0161enie. Tieto obmedzenia upriamili pozornos\u0165 na ivermekt\u00edn, liek, ktor\u00fd nielen \u00fa\u010dinne ni\u010d\u00ed rozto\u010de, ale aj zni\u017euje z\u00e1pal. Jeho dvojit\u00fd \u00fa\u010dinok bojuje proti pr\u00ed\u010dine aj pr\u00edznakom, \u010do d\u00e1va n\u00e1dej na trvalej\u0161ie v\u00fdsledky u pacientov, ktor\u00ed bojuj\u00fa s chronick\u00fdmi alebo opakuj\u00facimi sa probl\u00e9mami s Demodexom. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1542012419300655\" target=\"_blank\" rel=\"noopener\"><sup>11)<\/sup><\/a><\/p>\n<h2>Ako funguje ivermekt\u00edn na Demodex?<\/h2>\n<p>Ivermekt\u00edn je antiparazitikum so \u0161irok\u00fdm spektrom \u00fa\u010dinku, ktor\u00e9 sa desa <i>Demodex <\/i>spo\u010d\u00edva v jeho schopnosti viaza\u0165 sa na \u0161pecifick\u00e9 i\u00f3nov\u00e9 kan\u00e1ly v nervov\u00fdch a svalov\u00fdch bunk\u00e1ch parazita. P\u00f4soben\u00edm na chloridov\u00e9 kan\u00e1ly regulovan\u00e9 glutam\u00e1tom sp\u00f4sobuje ivermekt\u00edn paral\u00fdzu a nakoniec smr\u0165 rozto\u010dov, pri\u010dom zost\u00e1va bezpe\u010dn\u00fd pre \u013eudsk\u00e9 bunky, ktor\u00e9 nemaj\u00fa tieto \u0161trukt\u00fary. Na rozdiel od mnoh\u00fdch tradi\u010dn\u00fdch terapi\u00ed, ktor\u00e9 predov\u0161etk\u00fdm zmier\u0148uj\u00fa z\u00e1pal alebo zmier\u0148uj\u00fa pr\u00edznaky, ivermekt\u00edn priamo bojuje proti pr\u00ed\u010dine ochorenia t\u00fdm, \u017ee odstra\u0148uje samotn\u00e9 rozto\u010de. Tento mechanizmus ho rob\u00ed obzvl\u00e1\u0161\u0165 cenn\u00fdm v pretrv\u00e1vaj\u00facich alebo opakuj\u00facich sa pr\u00edpadoch, ke\u010f \u0161tandardn\u00e9 kr\u00e9my alebo hygienick\u00e9 pr\u00edpravky nedok\u00e1\u017eu poskytn\u00fa\u0165 trval\u00e9 v\u00fdsledky. (<a href=\"https:\/\/jag.journalagent.com\/eer\/pdfs\/EER_1_3_167_169.pdf\" target=\"_blank\" rel=\"noopener\"><sup>12)<\/sup><\/a><\/p>\n<h3>Lok\u00e1lne pou\u017eitie ivermekt\u00ednu pri lie\u010dbe ko\u017enej nevo\u013enosti<\/h3>\n<p>Lok\u00e1lne kr\u00e9my s ivermekt\u00ednom sa stali prelomovou lie\u010dbou ko\u017en\u00fdch ochoren\u00ed spojen\u00fdch s rozto\u010dmi Demodex, najm\u00e4 rosacey. Pacienti pou\u017e\u00edvaj\u00faci ivermekt\u00edn \u010dasto uv\u00e1dzaj\u00fa v\u00fdrazn\u00e9 zlep\u0161enie nielen za\u010dervenania a papuliek, ale aj celkov\u00e9ho komfortu poko\u017eky. Jeho dvojit\u00fd \u00fa\u010dinok - ni\u010denie rozto\u010dov a zni\u017eovanie z\u00e1palov\u00fdch reakci\u00ed - ho odli\u0161uje od star\u0161\u00edch l\u00e1tok, ako je metronidazol, ktor\u00e9 kontroluj\u00fa najm\u00e4 z\u00e1pal.<\/p>\n<p>\u010eal\u0161ou v\u00fdhodou je priazniv\u00fd profil tolerancie. V\u00e4\u010d\u0161ina \u013eud\u00ed poci\u0165uje minim\u00e1lne podr\u00e1\u017edenie a v porovnan\u00ed s agres\u00edvnej\u0161\u00edmi mo\u017enos\u0165ami, ako je napr\u00edklad \u010dajovn\u00edkov\u00fd olej, je \u010dasto jednoduch\u0161ie pokra\u010dova\u0165 v lie\u010dbe z dlhodob\u00e9ho h\u013eadiska. Pre pacientov, ktor\u00ed bojuj\u00fa s opakovan\u00fdm za\u010dervenan\u00edm tv\u00e1re, svrben\u00edm alebo p\u013euzgiermi spojen\u00fdmi s nadmern\u00fdm rastom rozto\u010dov, poskytuje lok\u00e1lny ivermekt\u00edn trvalej\u0161ie rie\u0161enie. <a href=\"https:\/\/jag.journalagent.com\/eer\/pdfs\/EER_1_3_167_169.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(12)<\/sup><\/a><\/p>\n<h3>Peror\u00e1lny ivermekt\u00edn v \u0165a\u017ek\u00fdch alebo refrakt\u00e9rnych pr\u00edpadoch<\/h3>\n<p>Pacientom s rozsiahlej\u0161\u00edmi alebo rezistentn\u00fdmi infekciami sa m\u00f4\u017ee predp\u00edsa\u0165 peror\u00e1lny ivermekt\u00edn. Peror\u00e1lne pod\u00e1vanie zabezpe\u010duje syst\u00e9mov\u00fa distrib\u00faciu lieku, v\u010faka \u010domu je \u00fa\u010dinn\u00fd pri stavoch, ako je napr\u00edklad chrastovit\u00e1 nevo\u013enos\u0165 alebo pr\u00edpady postihuj\u00face ko\u017eu aj povrch o\u010d\u00ed.<\/p>\n<p>Spr\u00e1vy z klinickej praxe ukazuj\u00fa, \u017ee u pacientov, ktor\u00ed boli ne\u00faspe\u0161n\u00ed pri viacer\u00fdch lok\u00e1lnych terapi\u00e1ch, \u010dasto doch\u00e1dza k v\u00fdraznej \u00fa\u013eave pri podan\u00ed jednej alebo dvoch peror\u00e1lnych d\u00e1vok ivermekt\u00ednu, niekedy v kombin\u00e1cii s lok\u00e1lnou lie\u010dbou na posilnenie \u00fa\u010dinku. Peror\u00e1lna lie\u010dba je obzvl\u00e1\u0161\u0165 u\u017eito\u010dn\u00e1 u jedincov so zn\u00ed\u017eenou imunitou ( ), u ktor\u00fdch sa popul\u00e1cie rozto\u010dov m\u00f4\u017eu nekontrolovate\u013ene mno\u017ei\u0165 a sp\u00f4sobova\u0165 rozsiahle pr\u00edznaky. <a href=\"https:\/\/jag.journalagent.com\/eer\/pdfs\/EER_1_3_167_169.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(12)<\/sup><\/a><\/p>\n<h2>Pou\u017eitie ivermekt\u00ednu v oftalmol\u00f3gii<\/h2>\n<p>Postihnutie o\u010d\u00ed, najm\u00e4 z\u00e1pal o\u010dn\u00fdch vie\u010dok sp\u00f4soben\u00fd <i>Demodex<\/i>, zost\u00e1va jedn\u00fdm z najhor\u0161\u00edch stavov, ktor\u00e9 sa lie\u010dia konven\u010dn\u00fdmi met\u00f3dami. Hoci utierky s \u010dajovn\u00edkov\u00fdm olejom m\u00f4\u017eu zn\u00ed\u017ei\u0165 hustotu rozto\u010dov, nie v\u017edy s\u00fa tolerovan\u00e9 v okol\u00ed citliv\u00e9ho okraja vie\u010dka.<\/p>\n<p>Ivermekt\u00edn v peror\u00e1lnej forme aj ako lok\u00e1lny kr\u00e9m, ktor\u00fd sa opatrne nan\u00e1\u0161a na spodok mihaln\u00edc, s\u013eubne zni\u017euje po\u010det rozto\u010dov a zmier\u0148uje pr\u00edznaky, ako je svrbenie, chrasty a such\u00e9 o\u010di. Pacienti, ktor\u00ed predt\u00fdm pou\u017e\u00edvali dlhodob\u00e9 pr\u00edpravky na hygienu o\u010dn\u00fdch vie\u010dok, po cielenej lie\u010dbe ivermekt\u00ednom \u010dasto poci\u0165uj\u00fa trvalej\u0161iu \u00fa\u013eavu. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0002939410009529\" target=\"_blank\" rel=\"noopener\"><sup>(13)<\/sup><\/a><\/p>\n<h2>Pre\u010do ivermekt\u00edn vynik\u00e1<\/h2>\n<ul>\n<li>Rast\u00face uznanie \u00falohy ivermekt\u00ednu v dermatol\u00f3gii a oftalmol\u00f3gii odr\u00e1\u017ea jeho jedine\u010dn\u00e9 v\u00fdhody:<\/li>\n<li><b>Priamy akaric\u00eddny \u00fa\u010dinok <\/b>- \u00fa\u010dinne zni\u017euje po\u010det rozto\u010dov.<\/li>\n<li><b>Protiz\u00e1palov\u00e9 vlastnosti <\/b>- upokojuje za\u010dervenanie a podr\u00e1\u017edenie.<\/li>\n<li><b>Dobr\u00e1 tolerancia <\/b>- menej ved\u013eaj\u0161\u00edch \u00fa\u010dinkov v porovnan\u00ed so siln\u00fdmi pr\u00edrodn\u00fdmi liekmi.<\/li>\n<\/ul>\n<p><b>Flexibilita <\/b>- v z\u00e1vislosti od z\u00e1va\u017enosti pr\u00edznakov je k dispoz\u00edcii v lok\u00e1lnej aj peror\u00e1lnej forme.<\/p>\n<p>Tieto kombinovan\u00e9 v\u00fdhody robia z ivermekt\u00ednu cenn\u00fd doplnok k lie\u010dbe ochoren\u00ed s\u00favisiacich s Demodexom, ktor\u00fd vyp\u013a\u0148a medzery po star\u0161\u00edch terapi\u00e1ch, ktor\u00e9 boli bu\u010f pr\u00edli\u0161 slab\u00e9, alebo pr\u00edli\u0161 dr\u00e1\u017ediv\u00e9 na dlhodob\u00e9 pou\u017e\u00edvanie. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>(14)<\/sup><\/a><\/p>\n<h2>V\u00fdhody ivermekt\u00ednu oproti tradi\u010dnej lie\u010dbe<\/h2>\n<h3>Priama kontrola rozto\u010dov<\/h3>\n<p>Jednou z najd\u00f4le\u017eitej\u0161\u00edch v\u00fdhod ivermekt\u00ednu je jeho schopnos\u0165 priamo kontrolova\u0165 a ni\u010di\u0165 rozto\u010de <i>Demodex<\/i>. Tradi\u010dn\u00e9 lie\u010debn\u00e9 postupy, ako je metronidazol, p\u00f4sobia predov\u0161etk\u00fdm na kontrolu z\u00e1palu, a nie na odstr\u00e1nenie jeho pr\u00ed\u010diny. To znamen\u00e1, \u017ee aj ke\u010f za\u010dervenanie alebo podr\u00e1\u017edenie do\u010dasne ust\u00fapi, rozto\u010de \u010dasto zost\u00e1vaj\u00fa, \u010do nakoniec vedie k recid\u00edve. Ivermekt\u00edn naproti tomu p\u00f4sob\u00ed tak, \u017ee rozto\u010de paralyzuje a usmrcuje, \u010d\u00edm zni\u017euje pravdepodobnos\u0165 recid\u00edvy a poskytuje trvalej\u0161ie v\u00fdsledky. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>14)<\/sup><\/a><\/p>\n<h3>Du\u00e1lny antiparazit\u00e1rny a protiz\u00e1palov\u00fd \u00fa\u010dinok<\/h3>\n<p>Ivermekt\u00edn je jedine\u010dn\u00fd v tom, \u017ee kombinuje antiparazit\u00e1rny a protiz\u00e1palov\u00fd \u00fa\u010dinok. Odstr\u00e1nen\u00edm rozto\u010dov odstra\u0148uje pr\u00ed\u010dinu z\u00e1palu a z\u00e1rove\u0148 inhibuje z\u00e1palov\u00e9 medi\u00e1tory, ktor\u00e9 sp\u00f4sobuj\u00fa za\u010dervenanie a citlivos\u0165 ko\u017ee. V\u010faka tomuto dvojit\u00e9mu \u00fa\u010dinku je obzvl\u00e1\u0161\u0165 \u00fa\u010dinn\u00fd pri rosacei a prim\u00e1rnej demodekt\u00f3ze, kde nadmern\u00fd rast rozto\u010dov priamo sp\u00f4sobuje z\u00e1pal ko\u017ee. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>(14)<\/sup><\/a><\/p>\n<h3>Zlep\u0161en\u00e1 tolerancia pacienta<\/h3>\n<p>\u00daspech dlhodobej lie\u010dby \u010dasto z\u00e1vis\u00ed od dodr\u017eiavania lie\u010debn\u00e9ho re\u017eimu pacientom. Hoci \u010dajovn\u00edkov\u00fd olej v laborat\u00f3rnych \u0161t\u00fadi\u00e1ch preuk\u00e1zal siln\u00fa aktivitu proti rozto\u010dom, jeho praktick\u00e9 pou\u017eitie je obmedzen\u00e9 podr\u00e1\u017eden\u00edm, pocitmi p\u00e1lenia a alergick\u00fdmi reakciami. Podobne aj permetr\u00edn m\u00f4\u017ee pri opakovanom pou\u017e\u00edvan\u00ed sp\u00f4sobi\u0165 vysu\u0161enie a svrbenie. Na druhej strane, ivermekt\u00edn sa vo v\u0161eobecnosti dobre zn\u00e1\u0161a. Lok\u00e1lne aj peror\u00e1lne pr\u00edpravky maj\u00fa relat\u00edvne mierny profil ved\u013eaj\u0161\u00edch \u00fa\u010dinkov, \u010do umo\u017e\u0148uje pacientom dokon\u010di\u0165 lie\u010dbu bez v\u00fdrazn\u00fdch \u0165a\u017ekost\u00ed. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>14)<\/sup><\/a><\/p>\n<h3>Ni\u017e\u0161ia miera recid\u00edvy<\/h3>\n<p>Recid\u00edvy s\u00fa \u010dast\u00fdm probl\u00e9mom pri lie\u010dbe ochoren\u00ed s\u00favisiacich s Demodexom. Lie\u010dba, ktor\u00e1 len zmier\u0148uje pr\u00edznaky, ako s\u00fa antibiotik\u00e1 alebo protiz\u00e1palov\u00e9 kr\u00e9my, \u010dasto vedie ku kr\u00e1tkodobej \u00fa\u013eave. \u0160t\u00fadie a klinick\u00e9 spr\u00e1vy neust\u00e1le dokazuj\u00fa, \u017ee u pacientov lie\u010den\u00fdch ivermekt\u00ednom doch\u00e1dza k dlh\u0161iemu obdobiu remisie. Je to sp\u00f4soben\u00e9 t\u00fdm, \u017ee liek bojuje proti pr\u00ed\u010dine infekcie, a nie len zmier\u0148uje reakciu organizmu na \u0148u. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>(14)<\/sup><\/a><\/p>\n<h3>Flexibilita mo\u017enost\u00ed lie\u010dby<\/h3>\n<p>\u010eal\u0161ou v\u00fdhodou ivermekt\u00ednu je flexibilita pod\u00e1vania. Lok\u00e1lne kr\u00e9my dobre funguj\u00fa pri lok\u00e1lnych ko\u017en\u00fdch l\u00e9zi\u00e1ch, zatia\u013e \u010do peror\u00e1lne pr\u00edpravky s\u00fa \u00fa\u010dinn\u00e9 v z\u00e1va\u017en\u00fdch alebo refrakt\u00e9rnych pr\u00edpadoch vr\u00e1tane o\u010dnej demodekt\u00f3zy a rozsiahlej ko\u017enej infekcie. T\u00e1to univerz\u00e1lnos\u0165 umo\u017e\u0148uje lek\u00e1rom prisp\u00f4sobi\u0165 lie\u010dbu z\u00e1va\u017enosti ochorenia, preferenci\u00e1m pacienta a \u00farovni tolerancie. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>(14<\/sup><\/a>)<\/p>\n<h2>\u00da\u010dinnos\u0165 pri o\u010dnej demodekoze<\/h2>\n<p>O\u010dn\u00e9 l\u00e9zie sa lie\u010dia obzvl\u00e1\u0161\u0165 \u0165a\u017eko kv\u00f4li citlivosti okrajov vie\u010dok. Mnoh\u00ed pacienti bojuj\u00fa s p\u00e1len\u00edm alebo p\u00e1len\u00edm sp\u00f4soben\u00fdm \u010dajovn\u00edkov\u00fdm olejom alebo zis\u0165uj\u00fa, \u017ee samotn\u00e1 hygiena o\u010dn\u00fdch vie\u010dok neprin\u00e1\u0161a dlhodob\u00fd \u00fa\u017eitok. Ivermekt\u00edn pon\u00faka alternat\u00edvu, ktor\u00e1 je \u00fa\u010dinn\u00e1 a z\u00e1rove\u0148 pohodlnej\u0161ia na pou\u017e\u00edvanie. Bolo zaznamenan\u00e9, \u017ee zlep\u0161uje nielen z\u00e1pal o\u010dn\u00fdch vie\u010dok, ale aj sekund\u00e1rne stavy, ako s\u00fa pr\u00edznaky syndr\u00f3mu such\u00e9ho oka, ktor\u00e9 po odstr\u00e1nen\u00ed rozto\u010dov \u010dasto ust\u00fapia. (<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S2405673125000546\" target=\"_blank\" rel=\"noopener\"><sup>(1)\u00a0 (4)\u00a0 ())<\/sup><\/a><\/p>\n<h2>Bezpe\u010dnej\u0161\u00ed dlhodob\u00fd profil v porovnan\u00ed s alternat\u00edvnymi met\u00f3dami<\/h2>\n<p>Dlhodob\u00e9 pou\u017e\u00edvanie syst\u00e9mov\u00fdch antibiot\u00edk na lie\u010dbu rosacey alebo neopl\u00e1zie prin\u00e1\u0161a riziko vzniku rezistencie na antibiotik\u00e1, ktor\u00e1 predstavuje celosvetovo rast\u00faci probl\u00e9m. Retinoidy, hoci s\u00fa niekedy \u00fa\u010dinn\u00e9, m\u00f4\u017eu sp\u00f4sobova\u0165 z\u00e1va\u017en\u00e9 ved\u013eaj\u0161ie \u00fa\u010dinky a vy\u017eaduj\u00fa si d\u00f4kladn\u00e9 monitorovanie. Bylinn\u00e9 pr\u00edpravky, hoci s\u00fa popul\u00e1rne, nie s\u00fa \u0161tandardizovan\u00e9 a m\u00f4\u017eu sp\u00f4sobi\u0165 nepredv\u00eddate\u013en\u00e9 reakcie. Naopak, ivermekt\u00edn m\u00e1 v\u010faka desa\u0165ro\u010diam pou\u017e\u00edvania pri lie\u010dbe parazit\u00e1rnych ochoren\u00ed dobre vybudovan\u00fa poves\u0165 bezpe\u010dn\u00e9ho lieku, tak\u017ee je spo\u013eahlivej\u0161ou vo\u013ebou pri chronick\u00fdch ochoreniach. (<a href=\"https:\/\/academic.oup.com\/jac\/article-abstract\/75\/4\/827\/5710696\" target=\"_blank\" rel=\"noopener\"><sup>15)<\/sup><\/a><\/p>\n<h2>Pre\u010do je to d\u00f4le\u017eit\u00e9 pre pacientov<\/h2>\n<p>Kone\u010dn\u00fdm meradlom \u00faspechu pri lie\u010dbe ochorenia spojen\u00e9ho s Demodexom je kvalita \u017eivota pacienta. Pretrv\u00e1vaj\u00face za\u010dervenanie, svrbenie a podr\u00e1\u017edenie o\u010d\u00ed m\u00f4\u017ee v\u00fdrazne ovplyvni\u0165 sebavedomie, v\u00fdkonnos\u0165 v pr\u00e1ci a soci\u00e1lne vz\u0165ahy. T\u00fdm, \u017ee ivermekt\u00edn poskytuje trvalej\u0161iu a dlhotrvaj\u00facu \u00fa\u013eavu, prin\u00e1\u0161a pacientom nielen zlep\u0161enie zdravotn\u00e9ho stavu, ale aj psychologick\u00e9 v\u00fdhody a v\u00fdhody v oblasti \u017eivotn\u00e9ho \u0161t\u00fdlu. <a href=\"https:\/\/academic.oup.com\/jac\/article-abstract\/75\/4\/827\/5710696\" target=\"_blank\" rel=\"noopener\"><sup>(15)<\/sup><\/a><\/p>\n<h2>Ivermekt\u00edn v zlo\u017eit\u00fdch pr\u00edpadoch Demodex a \u0161ir\u0161ie zdravotn\u00e9 aplik\u00e1cie<\/h2>\n<h3>Boj proti rezistentn\u00fdm alebo z\u00e1va\u017en\u00fdm infekci\u00e1m sp\u00f4soben\u00fdm Demodexom<\/h3>\n<p>Nie v\u0161etky zamorenia Demodexom reaguj\u00fa rovnako na \u0161tandardn\u00e9 kr\u00e9my alebo g\u00e9ly. U niektor\u00fdch pacientov, najm\u00e4 u t\u00fdch, u ktor\u00fdch doch\u00e1dza k opakovan\u00fdm exacerb\u00e1ci\u00e1m alebo maj\u00fa vysok\u00fa hustotu rozto\u010dov, lok\u00e1lne roztoky neposkytuj\u00fa trval\u00fa \u00fa\u013eavu. V tak\u00fdchto \u0165a\u017ek\u00fdch pr\u00edpadoch zohr\u00e1va jedine\u010dn\u00fa \u00falohu peror\u00e1lny ivermekt\u00edn. Na rozdiel od lok\u00e1lnych terapi\u00ed prenik\u00e1 syst\u00e9mov\u00fdm obehom hlb\u0161ie, \u010d\u00edm zabezpe\u010duje, \u017ee sa liek dostane k rozto\u010dom ukryt\u00fdm v mazov\u00fdch \u017e\u013eaz\u00e1ch a vlasov\u00fdch folikuloch. V\u010faka tomu je ivermekt\u00edn obzvl\u00e1\u0161\u0165 cenn\u00fd, ke\u010f konven\u010dn\u00e1 lie\u010dba dosiahne plat\u00f3. (<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s00436-024-08223-z\" target=\"_blank\" rel=\"noopener\"><sup>16)<\/sup><\/a><\/p>\n<h3>Demodex a imunokompromitovan\u00ed pacienti<\/h3>\n<p>Pacienti s oslaben\u00fdm imunitn\u00fdm syst\u00e9mom, ako napr\u00edklad pacienti trpiaci chronick\u00fdmi ochoreniami, lie\u010den\u00ed na rakovinu alebo star\u0161\u00ed \u013eudia, \u010dasto trpia premno\u017een\u00edm Demodexu. Ich poko\u017eka \u010dasto vykazuje pretrv\u00e1vaj\u00face za\u010dervenanie, zhrubnutie a dokonca \u0161upinatenie, ktor\u00e9 neustupuje ani po lok\u00e1lnej lie\u010dbe. Ivermekt\u00edn svoj\u00edm syst\u00e9mov\u00fdm \u00fa\u010dinkom bojuje proti popul\u00e1cii rozto\u010dov pri ich zdroji a zni\u017euje mno\u017estvo sp\u00fa\u0161\u0165a\u010dov z\u00e1palu, ktor\u00e9 vznikaj\u00fa v prostred\u00ed so zn\u00ed\u017eenou imunitou. U tak\u00fdchto pacientov vedie peror\u00e1lne pod\u00e1vanie ivermekt\u00ednu \u010dasto k r\u00fdchlej\u0161iemu hojeniu a zmierneniu pr\u00edznakov v porovnan\u00ed s alternat\u00edvnymi lok\u00e1lnymi pr\u00edpravkami. (<a href=\"https:\/\/www.mdpi.com\/2076-0817\/10\/7\/812\" target=\"_blank\" rel=\"noopener\"><sup>17)<\/sup><\/a><\/p>\n<h3>Sk\u00fasenosti z\u00edskan\u00e9 zo \u0161ir\u0161\u00edch aplik\u00e1ci\u00ed<\/h3>\n<p>Hoci ivermekt\u00edn nebol p\u00f4vodne vyvinut\u00fd na lie\u010dbu ko\u017en\u00fdch ochoren\u00ed, jeho \u00faspe\u0161n\u00e9 pou\u017e\u00edvanie v programoch kontroly parazit\u00e1rnych ochoren\u00ed na celom svete poukazuje na jeho bezpe\u010dnos\u0165 a dostupnos\u0165. Tieto rozsiahle intervencie uk\u00e1zali, ako m\u00f4\u017ee ma\u0165 jeden liek pozit\u00edvny vplyv na viacer\u00e9 ochorenia. Prenos t\u00fdchto sk\u00fasenost\u00ed na lie\u010dbu Demodexu je s\u013eubn\u00fd, najm\u00e4 v komunit\u00e1ch, kde s\u00fa ko\u017en\u00e9 ochorenia be\u017en\u00e9, ale \u0161pecializovan\u00e9 dermatologick\u00e9 slu\u017eby s\u00fa nedostato\u010dn\u00e9.<\/p>\n<h2>Bezpe\u010dnos\u0165, dostupnos\u0165 a ot\u00e1zky t\u00fdkaj\u00face sa pacientov<\/h2>\n<h3>Bezpe\u010dnos\u0165 a zn\u00e1\u0161anlivos\u0165 - lok\u00e1lne a peror\u00e1lne pou\u017eitie<\/h3>\n<p>Lok\u00e1lny ivermekt\u00edn (kr\u00e9m 1%) sa vo v\u0161eobecnosti dobre zn\u00e1\u0161a; v\u00e4\u010d\u0161ina pacientov uv\u00e1dza len mierne, prechodn\u00e9 pr\u00edznaky, ako je lok\u00e1lne p\u00e1lenie, suchos\u0165 alebo pocit pichania v mieste aplik\u00e1cie. Z\u00e1va\u017en\u00e9 ne\u017eiaduce reakcie spojen\u00e9 s pou\u017e\u00edvan\u00edm u v dermatol\u00f3gii s\u00fa zriedkav\u00e9. Peror\u00e1lny ivermekt\u00edn, ktor\u00fd sa pou\u017e\u00edva pri rozsiahlej\u0161\u00edch alebo refrakt\u00e9rnych infekci\u00e1ch, m\u00e1 tie\u017e priazniv\u00fd bezpe\u010dnostn\u00fd profil pri \u0161tandardn\u00fdch d\u00e1vkovac\u00edch re\u017eimoch. Naj\u010dastej\u0161ie hl\u00e1sen\u00fdmi ne\u017eiaducimi reakciami s\u00fa mierne syst\u00e9mov\u00e9 reakcie - z\u00e1vraty, nevo\u013enos\u0165, boles\u0165 hlavy alebo prechodn\u00fd pruritus. Z\u00e1va\u017en\u00e1 syst\u00e9mov\u00e1 toxicita je pri dodr\u017eiavan\u00ed d\u00e1vkovac\u00edch pokynov zriedkav\u00e1. (<a href=\"https:\/\/academic.oup.com\/jac\/article-abstract\/75\/4\/827\/5710696\" target=\"_blank\" rel=\"noopener\"><sup>15)<\/sup><\/a><\/p>\n<h3>Kontraindik\u00e1cie a \u0161peci\u00e1lne skupiny<\/h3>\n<p>Pou\u017e\u00edvaniu ivermekt\u00ednu po\u010das tehotenstva a u ve\u013emi mal\u00fdch det\u00ed (zvy\u010dajne s hmotnos\u0165ou ni\u017e\u0161ou ako 15 kg) sa vo v\u0161eobecnosti vyh\u00fdbame vzh\u013eadom na ne\u00fapln\u00e9 \u00fadaje o bezpe\u010dnosti lieku v t\u00fdchto skupin\u00e1ch. U pacientov s \u0165a\u017ek\u00fdm ochoren\u00edm pe\u010dene je potrebn\u00e9 postupova\u0165 opatrne, preto\u017ee ivermekt\u00edn sa metabolizuje v pe\u010deni. U pacientov so zn\u00ed\u017eenou imunitou m\u00f4\u017ee pr\u00ednos prev\u00e1\u017ei\u0165 nad rizikami, ale lie\u010dba sa m\u00e1 koordinova\u0165 s o\u0161etruj\u00facim lek\u00e1rom. Pri aplik\u00e1cii na o\u010di sa maj\u00fa lok\u00e1lne pr\u00edpravky pou\u017e\u00edva\u0165 opatrne, aby sa predi\u0161lo podr\u00e1\u017edeniu o\u010d\u00ed; peror\u00e1lnu lie\u010dbu o\u010dn\u00fdch ochoren\u00ed m\u00e1 pod\u013ea mo\u017enosti vies\u0165 oftalmol\u00f3g. (<a href=\"https:\/\/academic.oup.com\/jac\/article-abstract\/75\/4\/827\/5710696\" target=\"_blank\" rel=\"noopener\"><sup>15)<\/sup><\/a><\/p>\n<h3>Interakcie s in\u00fdmi liekmi a zriedkav\u00e9 neurologick\u00e9 pr\u00edhody<\/h3>\n<p>Hoci je ivermekt\u00edn v terapeutick\u00fdch d\u00e1vkach zriedkav\u00fd, je substr\u00e1tom pre transport\u00e9ry lie\u010div (napr. P-glykoprote\u00edn). S\u00fabe\u017en\u00e9 u\u017e\u00edvanie siln\u00fdch inhib\u00edtorov P-gp alebo liekov, ktor\u00e9 menia pe\u010de\u0148ov\u00fd metabolizmus, by teoreticky mohlo zv\u00fd\u0161i\u0165 syst\u00e9mov\u00e9 koncentr\u00e1cie ivermekt\u00ednu, preto by mal lek\u00e1r zv\u00e1\u017ei\u0165 s\u00fabe\u017en\u00e9 u\u017e\u00edvanie liekov. V literat\u00fare boli hl\u00e1sen\u00e9 ve\u013emi zriedkav\u00e9 neurologick\u00e9 ne\u017eiaduce udalosti (zm\u00e4tenos\u0165, ataxia), zvy\u010dajne spojen\u00e9 s pred\u00e1vkovan\u00edm alebo \u0161pecifickou citlivos\u0165ou; pou\u017e\u00edvanie odpor\u00fa\u010dan\u00fdch d\u00e1vok minimalizuje toto riziko. (<a href=\"https:\/\/academic.oup.com\/jac\/article-abstract\/75\/4\/827\/5710696\" target=\"_blank\" rel=\"noopener\"><sup>15)<\/sup><\/a><\/p>\n<h2>Smery \u010fal\u0161ieho v\u00fdskumu<\/h2>\n<p>Bud\u00face pr\u00e1ce by sa mali prioritne zamera\u0165 na randomizovan\u00e9 kontrolovan\u00e9 \u0161t\u00fadie porovn\u00e1vaj\u00face peror\u00e1lne a lok\u00e1lne re\u017eimy ivermekt\u00ednu na lie\u010dbu ko\u017enej a o\u010dnej demodekt\u00f3zy, \u0161tandardizovan\u00e9 protokoly kombinovanej lie\u010dby a d\u00f4sledn\u00e9 monitorovanie vznikaj\u00facej zn\u00ed\u017eenej citlivosti. V\u00fdvoj dobre tolerovan\u00fdch o\u010dn\u00fdch pr\u00edpravkov a \u0161t\u00fadie zah\u0155\u0148aj\u00face profilovanie ko\u017en\u00e9ho mikrobi\u00f3mu zlep\u0161ia v\u00fdber pacientov a personalizuj\u00fa lie\u010dbu. Potrebn\u00e9 s\u00fa aj ekonomick\u00e9 anal\u00fdzy, ktor\u00e9 pom\u00f4\u017eu vypracova\u0165 politiky na \u0161ir\u0161ie pou\u017e\u00edvanie lieku v podmienkach s obmedzen\u00fdmi zdrojmi. Z\u00e1verom mo\u017eno kon\u0161tatova\u0165, \u017ee ivermekt\u00edn - lok\u00e1lne a peror\u00e1lne aplikovan\u00fd - je \u00fa\u010dinn\u00fd, dobre tolerovan\u00fd a praktick\u00fd n\u00e1stroj v boji proti ochoreniu vyvolan\u00e9mu Demodexom. Ak sa pou\u017e\u00edva uv\u00e1\u017eene, pod\u013ea protokolov zalo\u017een\u00fdch na d\u00f4kazoch, s oh\u013eadom na bezpe\u010dnos\u0165 a dostupnos\u0165, m\u00f4\u017ee v\u00fdrazne zn\u00ed\u017ei\u0165 z\u00e1\u0165a\u017e rozto\u010dmi, zmierni\u0165 pr\u00edznaky a vyplni\u0165 kritick\u00e9 medzery, ktor\u00e9 zanechali tradi\u010dn\u00e9 terapie.<\/p>\n<h3>Zrieknutie sa zodpovednosti<\/h3>\n<p>Tento \u010dl\u00e1nok bol nap\u00edsan\u00fd na vzdel\u00e1vacie \u00fa\u010dely a jeho cie\u013eom je zv\u00fd\u0161i\u0165 povedomie o diskutovanej l\u00e1tke. Je d\u00f4le\u017eit\u00e9 poznamena\u0165, \u017ee \u010dl\u00e1nok sa t\u00fdka l\u00e1tky v\u0161eobecne - nie je to opis konkr\u00e9tneho v\u00fdrobku (chemick\u00e9ho \u010dinidla). Neodpor\u00fa\u010dame pou\u017e\u00edva\u0165 chemick\u00e9 \u010dinidl\u00e1 na \u013eu\u010foch - je to zak\u00e1zan\u00e9 z\u00e1konom. Aby sa v\u00fdrobok mohol pou\u017e\u00edva\u0165 na lie\u010dbu, mus\u00ed by\u0165 registrovan\u00fd ako liek. Inform\u00e1cie obsiahnut\u00e9 v texte s\u00fa zalo\u017een\u00e9 na dostupnom vedeckom v\u00fdskume a nie s\u00fa ur\u010den\u00e9 na lek\u00e1rske poradenstvo ani na podporu samolie\u010dby. \u010citate\u013e by mal v\u0161etky rozhodnutia t\u00fdkaj\u00face sa zdravia a lie\u010dby konzultova\u0165 s kvalifikovan\u00fdm zdravotn\u00edckym pracovn\u00edkom.<\/p>\n<h2>Odkazy<\/h2>\n<ol>\n<li>Aumond, S., &amp; Bitton, E. (2020). Napadnutie poko\u017eky dlane a tv\u00e1re hubou Demodex folliculorum.\u00a0<i>Kontaktn\u00e9 \u0161o\u0161ovky a predn\u00e1 \u010das\u0165 oka<\/i>,\u00a0<i>43<\/i>(2), 115-122.<\/li>\n<li>Nicholls, S. G., Oakley, C. L., Tan, A., &amp; Vote, B. J. (2017). Demodex species v o\u010dn\u00fdch ochoreniach u \u013eud\u00ed: nov\u00e9 klinicko-patologick\u00e9 aspekty.\u00a0<i>Medzin\u00e1rodn\u00e1 oftalmol\u00f3gia<\/i>,\u00a0<i>37<\/i>(1), 303-312.<\/li>\n<li>Zeytun, E. (2017). Napadnutie Demodex (Acari: Demodicidae) u star\u0161\u00edch \u013eud\u00ed a jeho vz\u0165ah k parametrom ko\u017ee, ako je vlhkos\u0165, pH a teplota: prierezov\u00e1 \u0161t\u00fadia.\u00a0<i>Turkish Journal of Geriatrics\/T\u00fcrk Geriatri Dergisi<\/i>,\u00a0<i>20<\/i>(2).<\/li>\n<li>Schaumberg, D. A., Nichols, J. J., Papas, E. B., Tong, L., Uchino, M., &amp; Nichols, K. K. (2011). Medzin\u00e1rodn\u00fd workshop o dysfunkcii meibomsk\u00fdch \u017eliaz: spr\u00e1va podv\u00fdboru pre epidemiol\u00f3giu a s\u00favisiace rizikov\u00e9 faktory MGD.\u00a0<i>Vy\u0161etrovacia oftalmol\u00f3gia a zrakov\u00e9 vedy<\/i>,\u00a0<i>52<\/i>(4), 1994-2005.<\/li>\n<li>Zhao, Y. E., Guo, N., Xun, M., Xu, J. R., Wang, M., &amp; Wang, D. L. (2011). Sociodemografick\u00e9 charakteristiky a anal\u00fdza rizikov\u00fdch faktorov zamorenia Demodexom (Acari: Demodicidae).\u00a0<i>\u010casopis Zhejiang University Science B<\/i>,\u00a0<i>12<\/i>(12), 998-1007.<\/li>\n<li>Zhao, Y. E., Guo, N., Xun, M., Xu, J. R., Wang, M., &amp; Wang, D. L. (2011). Sociodemografick\u00e9 charakteristiky a anal\u00fdza rizikov\u00fdch faktorov zamorenia Demodexom (Acari: Demodicidae).\u00a0<i>\u010casopis Zhejiang University Science B<\/i>,\u00a0<i>12<\/i>(12), 998-1007.<\/li>\n<li>Kaur, T., Jindal, N., Bansal, R., &amp; Mahajan, B. B. (2012). Demodicid\u00f3za tv\u00e1re: diagnostick\u00e1 v\u00fdzva.\u00a0<i>Indick\u00fd dermatologick\u00fd \u010dasopis<\/i>,\u00a0<i>57<\/i>(1), 72-73.<\/li>\n<li>Jacob, S., VanDaele, M. A., &amp; Brown, J. N. (2019). Lie\u010dba z\u00e1palov\u00fdch stavov ko\u017ee spojen\u00fdch s Demodexom: systematick\u00fd preh\u013ead.\u00a0<i>Dermatologick\u00e1 lie\u010dba<\/i>,\u00a0<i>32<\/i>(6), e13103.<\/li>\n<li>Karakurt, Y., &amp; Zeytun, E. (2018). Hodnotenie \u00fa\u010dinnosti tea tree oleja na hustotu rozto\u010dov Demodex (Acari: Demodicidae) a o\u010dn\u00e9 pr\u00edznaky u pacientov s demodektovou blefarit\u00eddou.\u00a0<i>Journal of Parasitology<\/i>,\u00a0<i>104<\/i>(5), 473-478.<\/li>\n<li>Jacob, S., VanDaele, M. A., &amp; Brown, J. N. (2019). Lie\u010dba z\u00e1palov\u00fdch stavov ko\u017ee spojen\u00fdch s Demodexom: systematick\u00fd preh\u013ead.\u00a0<i>Dermatologick\u00e1 lie\u010dba<\/i>,\u00a0<i>32<\/i>(6), e13103.<\/li>\n<li>Navel, V., Mulliez, A., d'Azy, C. B., Baker, J. S., Malecaze, J., Chiambaretta, F., &amp; Dutheil, F. (2019). \u00da\u010dinnos\u0165 lie\u010dby Demodex blefarit\u00eddy: systematick\u00fd preh\u013ead a metaanal\u00fdza.\u00a0<i>O\u010dn\u00fd povrch<\/i>,\u00a0<i>17<\/i>(4), 655-669.<\/li>\n<li>Ozcan, A. A., &amp; Ulas, B. (2021). Lok\u00e1lny ivermekt\u00edn v lie\u010dbe blefarokonjunktivit\u00eddy sp\u00f4sobenej zamoren\u00edm demodexom.<\/li>\n<li>Holzchuh, F. G., Hida, R. Y., Moscovici, B. K., Albers, M. B. V., Santo, R. M., Kara-Jos\u00e9, N., &amp; Holzchuh, R. (2011). Klinick\u00e1 lie\u010dba o\u010dn\u00e9ho Demodex folliculorum syst\u00e9mov\u00fdm ivermekt\u00ednom.\u00a0<i>Americk\u00fd oftalmologick\u00fd \u010dasopis<\/i>,\u00a0<i>151<\/i>(6), 1030-1034.<\/li>\n<li>Paichitrojjana, A., Khuancharee, K., &amp; Paichitrojjana, A. (2025). \u00da\u010dinnos\u0165 lok\u00e1lneho ivermekt\u00ednu pri kontrole zamorenia \u010dloveka Demodexom: D\u00f4kazy zo systematick\u00e9ho preh\u013eadu a metaanal\u00fdzy.\u00a0<i>Epidemiol\u00f3gia a kontrola parazitov<\/i>, e00461.<\/li>\n<li>Navarro, M., Camprub\u00ed, D., Requena-M\u00e9ndez, A., Buonfrate, D., Giorli, G., Kamgno, J., ... &amp; Krolewiecki, A. (2020). Bezpe\u010dnos\u0165 vysok\u00fdch d\u00e1vok ivermekt\u00ednu: systematick\u00fd preh\u013ead a metaanal\u00fdza.\u00a0<i>Journal of Antimicrobial Chemotherapy<\/i>,\u00a0<i>75<\/i>(4), 827-834.<\/li>\n<li>Al Harbi, S. M., Al Saif, N. M., Mawkili, A., &amp; Al Breiki, S. (2023). Hyperpigment\u00e1cia ko\u017ee vyvolan\u00e1 demodik\u00f3zou tv\u00e1re u imunokompromitovan\u00e9ho mu\u017ea \u00faspe\u0161ne lie\u010den\u00e9ho ivermekt\u00ednov\u00fdm kr\u00e9mom 1%: kazuistika.\u00a0<i>Klinick\u00e1, kozmetick\u00e1 a v\u00fdskumn\u00e1 dermatol\u00f3gia<\/i>, 1203-1207.<\/li>\n<li>Furnival-Adams, J., Kiuru, C., Sagna, A. B., Mouline, K., Maia, M., &amp; Chaccour, C. (2024). Mechanizmy rezistencie vo\u010di ivermekt\u00ednu u ektoparazitov: preh\u013ead rozsahu.\u00a0<i>Parazitologick\u00fd v\u00fdskum<\/i>,\u00a0<i>123<\/i>(5), 221.<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>Opis potenci\u00e1lneho p\u00f4sobenia l\u00e1tky ivermekt\u00edn na z\u00e1klade literat\u00fary. (Nie je to opis produktu, disclaimer na dole str\u00e1nky) Ivermekt\u00edn na Demodex (nu\u017eera) sa \u010doraz \u010dastej\u0161ie spom\u00edna ako...<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-37177","post","type-post","status-publish","format-standard","hentry","category-bez-kategorii","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts\/37177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/comments?post=37177"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/posts\/37177\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/media?parent=37177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/categories?post=37177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/sk\/wp-json\/wp\/v2\/tags?post=37177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}